Risperidone: A Pharmacoeconomic Review of its Use in Schizophrenia
Year of publication: |
1998
|
---|---|
Authors: | Foster, Rachel H. ; Goa, Karen L. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 14.1998, 1, p. 97-133
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Reviews-on-treatment | Pharmacoeconomics | Schizophrenia | Risperidone | Hospitalisation | Cost-utility | Quality-adjusted-life-years | Cost-effectiveness | Cost-of-illness | Cost-benefit | Antipsychotics | Quality-of-life | Drug-evaluations |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Olanzapine: A Pharmacoeconomic Review of its Use in Schizophrenia
Foster, Rachel H., (1999)
-
Management of Schizophrenia: Defining the Role of Long-Acting Injectable Risperidone
Curran, Monique P., (2006)
-
Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Pharmacoeconomic Review
Coukell, Allan J., (1999)
- More ...
-
Olanzapine: A Pharmacoeconomic Review of its Use in Schizophrenia
Foster, Rachel H., (1999)
-
Abciximab: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Revascularisation
Dunn, Christopher J., (1999)
-
Drotrecogin Alfa (Activated): A Pharmacoeconomic Review of its Use in Severe Sepsis
Frampton, James E., (2004)
- More ...